Abstract
Saquinavir boosted with low-dose ritonavir given with zidovudine and lamivudine was well tolerated by pregnant women and their infants. All mothers had <400 human immunodeficiency virus type 1 RNA copies/ml at delivery. Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2208-2210 |
| Number of pages | 3 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 51 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2007 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases